
2 Startups Awarded $175,000 Each to Further Develop Cancer Treatment Technologies
Riptide Therapeutics Awarded $175,000 From George Shultz Innovation Fund
Alnair Therapeutics Awarded $175,000 From George Shultz Innovation Fund
Multifunctional Nanomedicine Developed Using Novel UChicago Tech Gets FDA Nod to Initiate Clinical Trials
F3 Platform Biologics Developing Cancer-Preventing Drugs Based on the Work of UChicago Researcher
Patent of the Week: Precisely Delivering High Dose Radiation to Multiple Tumor Sites
Duckworth Family’s Partnership Drives Cancer Discoveries to Market
How Gut Microbes are Joining the Fight Against Cancer
City Club of Chicago: John Flavin, Polsky Center for Entrepreneurship and Innovation
Chicago Booth Entrepreneurs Launch Startup to Halt Cervical Cancer
25 Chicago Startups That Are Fighting Cancer
Will Harnessing Big Data Finally Lead to a Cure for Cancer?
This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.